|
The DIA Annual Meeting is the premier event for professionals involved in the discovery, development, and lifecycle management of pharmaceuticals, medical devices, and related products. There is no other industry meeting of its kind that can rival the breadth and depth of experience that this meeting delivers. With 25 content-area tracks, 330 sessions and 20 tutorials, presentations are geared to attendees at all disciplines, works settings, and experience levels. The DIA Annual Meeting, above all others, offers valuable professional cross-functional learning and networking experiences.
LEARNING OBJECTIVES At the conclusion of this meeting, participants should be able to:
- Compare and contrast the current regional regulatory and public policy environment pertaining to pharmaceuticals and related products
- Discuss the regulatory and economic factors that impact the global biopharmaceutical industry
- Recognize the challenges facing regulatory agencies and industry in research study design and statistical methodology
- Assess the progress toward integrated, state-of-the-art document management systems
- Identify legal, advertising, and marketing issues related to providing product information
- Apply principles of risk assessment and management to development and postmarket phases of new healthcare products
- Summarize issues in safety reporting and data analysis regarding adverse events
- Distinguish regional approaches to integration of evidence-based medicine and comparative effectiveness research into healthcare decision-making
- Describe current issues in designing and implementing clinical trials, including patient recruitment, site selection and management of multiregional clinical trials
- Identify current opportunities and challenges in the area of personalized medicine for disease treatment
WHO SHOULD ATTEND This program is designed for individuals involved in the involved in the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products. The program is intended to strengthen professionals' understanding of the value of cross-discipline integration and to foster innovation for better health outcomes. |
|
Preliminary Program - Digital Version - View Now
Schedule at a Glance - View Now
Special Sessions and Topics
The Annual Meeting features many sessions with topics focusing on issues affecting global drug discovery and development. - Find out more!
Testimonial
 Murray M. Lumpkin, MD, MSc Dr. Lumpkin is a 19-year career officer at the US Food and Drug Administration (FDA) and is the Deputy Commissioner (International and Special Programs).
|
|